KUALA LUMPUR (Oct 21): TMC Life Sciences Bhd saw its net profit for the three month period ended Aug 31, 2015 jump more than 290% to RM2.89 million or 0.24 sen per share, from RM728,000 or 0.09 sen per share a year earlier.

The better earnings was driven by higher revenue recorded and interest income earned.

Revenue for the quarter came in 29.8% higher at RM30.07 million, from RM23.17 million, contributed by higher patient load arising from additional consultants recruited.  

No dividend was declared for the current quarter under review.  

Going forward, TMC Life said the growth prospects for the healthcare sector in Malaysia remains positive, fuelled by changing demographics, a more affluent society, and more health-conscious lifestyles.

Nonetheless, the group continues to expand the breadth and diversity of their services to generate more revenue growth.

"With the 2 new wards, comprising 51 beds, completed on Sept 9, 2015, our hospital in Kota Damansara now [h]as a capacity of 200 beds," it added.  

Shares in TMC Life closed unchanged at 56 sen today, for a market capitalisation of RM979.06 million.

(Note: The Edge Research's fundamental score reflects a company's profitability and balance sheet strength, calculated based on historical numbers. The valuation score determines if a stock is attractively valued or not, also based on historical numbers. A score of 3 suggests strong fundamentals and attractive valuations.)